The stock of Aptose Biosciences Inc (TSE:APS) is a huge mover today! About 45,541 shares traded hands or 123.19% up from the average. Aptose Biosciences Inc (TSE:APS) has declined 16.57% since March 10, 2016 and is downtrending. It has underperformed by 22.18% the S&P500.
The move comes after 7 months negative chart setup for the $33.73M company. It was reported on Oct, 17 by Barchart.com. We have $2.52 PT which if reached, will make TSE:APS worth $4.05M less.
More news for Aptose Biosciences Inc (TSE:APS) were recently published by: Streetinsider.com, which released: “Aptose Biosciences (APTO) Updates on APTO-253 FDA Clinical Hold; Says …” on October 13, 2016. Quotes.Wsj.com‘s article titled: “News Aptose Biosciences Inc.APTO” and published on October 24, 2014 is yet another important article.
Aptose Biosciences Inc. is a clinical-stage biotechnology company. The company has a market cap of $33.73 million. The Firm is engaged in the development of anticancer drugs that target specific epigenetic processes and signal transduction abnormalities that underlie a particular life-threatening malignancy. It currently has negative earnings. The Company’s product pipeline includes cancer drug candidates that exert activity as stand-alone agents and that enhance the activities of other anticancer agents without causing overlapping toxicities.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.